Philip S. Khoury, PhDChairman of AUB Board of Trustees
A trustee since 1997, the chairman of the AUB Board of Trustees since 2009, and a former AUB student (’69-’70), Khoury is the Ford International Professor of History and associate provost at the Massachusetts Institute of Technology (MIT). He is former chairman of the World Peace Foundation, vice chairman of the Trinity College Board of Trustees, a trustee of the National Humanities Center, an overseer of Koç University in Istanbul, and a member of the Academic Research Council in Singapore. Khoury is a fellow of the American Academy of Arts and Sciences, a fellow of the American Association for the Advancement of Science, and a past president of the Middle East Studies Association. He received the Distinguished AUB Alumni Award in 2009. He is a graduate of Trinity College (AB ’71) and Harvard University (PhD ’80).
Fadlo R. Khuri, MDAUB President
Fadlo R. Khuri, MD, the 16th president of the American University of Beirut, assumed office on September 1, 2015. He previously held leadership positions at Emory University School of Medicine in Atlanta, Georgia. These included professor and chairman of the Department of Hematology and Medical Oncology, the Roberto C. Goizueta Distinguished Chair for Cancer Research, deputy director for the Winship Cancer Institute, and the executive associate dean for research. Born in Boston, Massachusetts, Khuri was raised in Beirut while his father Raja N. Khuri served as dean of the AUB’s Faculty of Medicine and his mother, Dr. Soumaya Makdisi Khuri, was a professor of mathematics. Following a year of study at AUB (1981-82), Khuri earned his undergraduate degree at Yale University in New Haven, and his MD at Columbia University, College of Physicians and Surgeons in New York. He completed a residency in Internal Medicine at the Boston City Hospital, and a fellowship in Hematology and Medical Oncology at the Tufts-New England Medical Center. Before joining Emory University in 2003, Khuri was on the faculty of the University of Texas MD Anderson Cancer Center for seven years. His research is focused on the development of molecular, prognostic, therapeutic, and chemopreventive approaches to improve the standard of care for patients with lung and aerodigestive cancers. Khuri’s work has been recognized with several major awards, including the 2006 Nagi Sahyoun Award of the Middle East Medical Assembly, the 2010 Waun Ki Hong Distinguished Professorship by the University of Texas MD Anderson Cancer Center, and the 2013 American Association for Cancer Research Richard and Hinda Rosenthal Memorial Award. He was elected to the Lebanese Academy of Sciences; is an elected member of the American Society for Clinical Investigation; and is a fellow of the American College of Physicians and of the American Association for the Advancement of Science. Dr. Khuri is married to Lamya Tannous Khuri. They have three children, Layla, Raja, and Rayya.
Hussein Ibish, PhDSenior Resident Scholar, Arab Gulf States Institute, Washington, DC, United States
Dr. Hussein Ibish is a senior resident scholar at the Arab Gulf States Institute inWashington. He is a regular columnist for The New York Times, and has written numerous books and essays. Ibish previously served as a senior fellow at the American Task Force on Palestine and executive director of the Foundation for Arab-American Leadership. He has a PhD in comparative literature from the University of Massachusetts Amherst.
Waun Ki Hong, MDFormer Head, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States
Dr. Waun Ki Hong is an American Cancer Society Professor and a Samsung Distinguished University Chair in Cancer Medicine. A leader in medical oncology, Dr. Hong is an authority on treatment and prevention of head and neck cancer and lung cancer. His expertise spans more than 36 years of advances in cancer research. Dr. Hong has played a role in shaping public policy, increasing collaboration in cancer research, and mentoring.
Ruth O’Regan, MDDivision Head, Hematology/OncologyAssociate Director of Faculty Development and Education, University of Wisconsin Carbone Cancer Center, Madison, WI, United States
Dr. Ruth O’Regan is an internationally recognized breast cancer physician and researcher. Her research is focused on developing novel therapies for resistant breast cancers. Dr. O’Regan was previously professor of hematology and medical oncology at Emory University and chief of hematology and medical oncology at the Georgia Cancer Center for Excellence.